Ten-year survival outcome of the nicotine transdermal patch with cognitive behavioural therapy
Article first published online: 7 JUN 2007
Australian and New Zealand Journal of Public Health
Volume 31, Issue 3, pages 282–285, June 2007
How to Cite
Richmond, R. L. and Kehoe, L. (2007), Ten-year survival outcome of the nicotine transdermal patch with cognitive behavioural therapy. Australian and New Zealand Journal of Public Health, 31: 282–285. doi: 10.1111/j.1467-842X.2007.00062.x
- Issue published online: 7 JUN 2007
- Article first published online: 7 JUN 2007
- Submitted: December 2006 Revision requested: March 2007 Accepted: May 2007
- smoking cessation;
- cognitive therapy
Objective: To follow-up abstainers from the end of their initial treatment over seven points to 10 years.
Methods: In the original study there were 305 smokers who were recruited in a double-blind randomised controlled trial. Those subjects who had remained continuously abstinent to seven years (n=20) were followed up to ascertain continuous smoking prevalence to 10 years. Main outcome measure was continuous abstinence.
Results: At 10 years, the active nicotine patch group showed significantly higher continuous abstinence rates that were double those of the placebo group (7.9% vs. 2.6%, respectively). The high rate of relapse declined after six months.
Conclusions: The nicotine patch leads to superior continuous abstinence over 10 years when compared with placebo.
Public health implications: This is the longest follow-up study of continuous smoking abstinence after cognitive behaviour treatment combined with the nicotine patch.